Ostrum Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.62M | Sell |
5,894
-452
| -7% | -$201K | 0.12% | 158 |
|
|
2025
Q1 | $3.08M | Sell |
6,346
-13
| -0.2% | -$6.3K | 0.16% | 118 |
|
|
2024
Q4 | $2.56M | Buy |
6,359
+1,086
| +21% | +$437K | 0.22% | 141 |
|
|
2024
Q3 | $2.45M | Sell |
5,273
-2,155
| -29% | -$1M | 0.2% | 180 |
|
|
2024
Q2 | $3.48M | Sell |
7,428
-1,893
| -20% | -$887K | 0.3% | 86 |
|
|
2024
Q1 | $3.9M | Buy |
9,321
+15
| +0.2% | +$6.27K | 0.31% | 85 |
|
|
2023
Q4 | $3.79M | Buy |
9,306
+477
| +5% | +$194K | 0.33% | 80 |
|
|
2023
Q3 | $3.07M | Sell |
8,829
-60
| -0.7% | -$20.9K | 0.28% | 93 |
|
|
2023
Q2 | $3.13M | Buy |
8,889
+8
| +0.1% | +$2.82K | 0.26% | 120 |
|
|
2023
Q1 | $2.8M | Buy |
+8,881
| New | +$2.8M | 0.24% | 137 |
|
|
2020
Q3 | $3.65M | Buy |
13,405
+1,010
| +8% | +$275K | 2.35% | 12 |
|
|
2020
Q2 | $3.6M | Buy |
12,395
+1,700
| +16% | +$493K | 2.14% | 11 |
|
|
2020
Q1 | $2.55M | Buy |
10,695
+1,100
| +11% | +$262K | 1.75% | 12 |
|
|
2019
Q4 | $2.1M | Hold |
9,595
| – | – | 1% | 22 |
|
|
2019
Q3 | $1.63M | Buy |
9,595
+900
| +10% | +$153K | 0.81% | 30 |
|
|
2019
Q2 | $1.59M | Buy |
8,695
+5,042
| +138% | +$924K | 0.44% | 78 |
|
|
2019
Q1 | $672K | Hold |
3,653
| – | – | 0.22% | 120 |
|
|
2018
Q4 | $605K | Buy |
+3,653
| New | +$605K | 0.24% | 117 |
|